BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18670743)

  • 1. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
    Yang P; Liang M; Zhang Y; Shen B
    Adv Ther; 2008 Aug; 25(8):787-94. PubMed ID: 18670743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR; Kang Z; Qian JS; Zhu KS; Jiang ZB; Huang MS; Guan SH; Shan H
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS
    Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
    Chok KS; Ng KK; Poon RT; Lam CM; Yuen J; Tso WK; Fan ST
    Arch Surg; 2006 Dec; 141(12):1231-6. PubMed ID: 17178966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
    Georgiades CS; Hong K; Geschwind JF
    Cancer J; 2008; 14(2):117-22. PubMed ID: 18391617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM; Qin H; Wang CB; Fang XH; Ma QY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
    Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH; Choi MS; Choi YS; Kim DY; Lee JM; Paik SW; Lee JH; Koh KC; Yoo BC; Choi D; Rhee JC
    Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.
    Shim SJ; Seong J; Han KH; Chon CY; Suh CO; Lee JT
    Liver Int; 2005 Dec; 25(6):1189-96. PubMed ID: 16343071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
    Shen H; Agarwal D; Qi R; Chalasani N; Liangpunsakul S; Lumeng L; Yoo H; Kwo P
    Aliment Pharmacol Ther; 2007 Aug; 26(3):393-400. PubMed ID: 17635374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.